In San Francisco a few weeks ago, I caught up with Nworah Ayogu, partner at Thrive Capital. Thrive had recently announced that it raised a

The US FDA has approved a fourth product via its new National Priority Voucher Programme — a 7.2 mg dose of Novo Nordisk’s weight loss

The FDA approved a high-dose version of Novo Nordisk’s blockbuster weight loss injection Wegovy, giving its go-ahead about two months faster than normal thanks to

Verily has raised $300 million in new, outside funding that ends parent company Alphabet’s controlling position in the healthcare innovation company, Endpoints News has learned

CSL Behring disclosed a “temporary global stockout” of its gene therapy for hemophilia B that it says could delay treatment for some patients. In a